| | Business Summary | | Cholestech
Corporation,
in
fiscal
2001,
engaged
in
three
business
activities:
Diagnostic
Products,
which
develops,
manufactures
and
markets
its
Cholestech
L-D-XSystem
(the
L-D-X
System),
which
performs
near-patient
diagnostic
tests
that
assist
in
assessing
the
risk
of
heart
disease,
certain
liver
diseases
and
in
the
monitoring
of
therapy
to
treat
those
diseases;
WellCheck,
which
conducts
cholesterol
testing
within
the
United
States
that
assesses
the
risk
of
heart
disease
and
assists
in
the
monitoring
of
therapy
to
treat
that
diseases;
and
WellCheck.com,
which
provides
interactive
tools
to
consumers
through
the
Internet
to
better
assess
the
risk
of
heart
disease
and
to
monitor
and
motivate
personal
health
management
of
that
disease.
The
Company
offers
a
variety
of
products
and
services
in
each
of
its
businesses,
including
products
currently
under
development. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | CTEC
develops,
manufactures
and
markets
the
Cholestech
L.D.X(R),
which
performs
near-patient
diagnostic
screening
and
therapeutic
monitoring
for
the
managment
of
prevalent
chronic
diseases.
For
the
13
weeks
ended
6/29/01,
revenues
rose
35%
to
$12.4
million.
Net
income
rose
31%
to
$1.2
million.
Results
reflect
strong
growth
in
sales
in
the
Diagnostic
Products
business
and
the
WellCheck
testing
services,
partially
offset
by
increased
sales
and
marketing
expenses. | | More
from
Market Guide: Significant
Developments |
| | | | FY2001
Compensation | | Pay | Exer | |
| John Landon, 60
Chairman | -- | -- | Warren Pinckert II, 57
Pres,
CEO, Director | $318K | $24K | William Burke, 42
CFO,
VP-Fin., Sec., Treasurer | -- | -- | Robert Dominici, 57
Exec.
VP of Sales and Marketing, COO of Diagnostic Products | 254K | -- | David Gyorke, 41
VP-Operations,
Diagnostic Products | -- | -- | | Dollar
amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/c/ctec.gif)